A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals

BACKGROUND: As there is limited data on the sustainability of desensitization of multifood-oral immunotherapy (multifood-OIT), we conducted a multisite multifood-OIT study to compare the efficacy of successful desensitization with sustained dosing vs discontinued dosing after multifood-OIT. METHODS:...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:EClinicalMedicine
Glavni autori: Andorf, Sandra, Purington, Natasha, Kumar, Divya, Long, Andrew, O'Laughlin, Katherine L., Sicherer, Scott, Sampson, Hugh, Cianferoni, Antonella, Whitehorn, Terri Brown, Petroni, Daniel, Makhija, Melanie, Robison, Rachel G., Lierl, Michelle, Logsdon, Stephanie, Desai, Manisha, Galli, Stephen J., Rael, Efren, Assa'ad, Amal, Chinthrajah, Sharon, Pongracic, Jacqueline, Spergel, Jonathan M., Tam, Jonathan, Tilles, Stephen, Wang, Julie, Nadeau, Kari
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537534/
https://ncbi.nlm.nih.gov/pubmed/31193674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2018.12.006
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items